Foamix Investigational Site #248 — Oldsmar, Florida

Foamix Investigational Site #248 is a clinical research site located in Oldsmar, Florida, United States 34677.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Foamix Investigational Site #248 has participated in 1 clinical trials.

Therapeutic areas: Facial Papulopustular Rosacea.

Sponsors: Vyne Therapeutics Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oldsmar

Browse all research sites in Florida · View every site in Oldsmar

• Journey Research Inc.
• Hisamitsu Investigator Site
• Novartis Investigative Site
• Investigational Site
• Forest Investigative Site 1950
• 1276.1.10024 Boehringer Ingelheim Investigational Site
• Tower Radiology Center
• Site Reference ID/Investigator# 54866
• Tonix Clinical Site
• Research Site
• GSK Investigational Site
• Bay Area Rheumatology

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Foamix Investigational Site #248?

Foamix Investigational Site #248 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Foamix Investigational Site #248 conducted?

Foamix Investigational Site #248 has 1 clinical trials on record. Their work covers Facial Papulopustular Rosacea.

Is Foamix Investigational Site #248 accredited by Crixeo Clinical Trials?

Foamix Investigational Site #248 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Foamix Investigational Site #248?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.